Showing results (1071-1080 of 1,921) with videos related to
Sort By:
Pageof 193
Current Atherosclerosis Reports|February 3, 2005
Antioxidants and atherosclerosis: emerging drug therapiesJean-Claude TardifCurrent Atherosclerosis Reports|November 24, 2022
The Dynamic Interplay of Healthy Lifestyle Behaviors for Cardiovascular HealthPenny M Kris-Etherton, Philip A Sapp, Terrance M Riley, et al.Current Atherosclerosis Reports|January 6, 2023
How ANGPTL3 Inhibition Will Help Our Clinical Practice?Simone Bini, Daniele Tramontano, Ilenia Minicocci, et al.Current Atherosclerosis Reports|December 29, 2022
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate ContinuesSamuel C R Sherratt, Peter Libby, Matthew J Budoff, et al.Current Atherosclerosis Reports|June 30, 2022
COVID-19 and Cardiometabolic Health: Lessons Gleaned from the Pandemic and Insights for the Next WaveAhmed A Kolkailah, Kayla Riggs, Ann Marie Navar, et al.Current Atherosclerosis Reports|June 28, 2021
Polygenic Risk Scores to Identify CVD Risk and Tailor Therapy: Hope or Hype?Charles A German, Michael D ShapiroCurrent Atherosclerosis Reports|June 19, 2021
The Role of RNA-Targeted Therapeutics to Reduce ASCVD Risk: What Have We Learned Recently?Marcio H Miname, Viviane Z Rocha, Raul D SantosCurrent Atherosclerosis Reports|May 27, 2022
Can We Mitigate Coronary Heart Disease Risk in Patients with Cancer?Hasitha Manohar, Adam S Potter, Efstratios Koutroumpakis, et al.Current Atherosclerosis Reports|May 24, 2023
Implementing Reporting Standards for Polygenic Risk Scores for Atherosclerotic Cardiovascular DiseaseJohanna L Smith, Daniel J Schaid, Iftikhar J KulloCurrent Atherosclerosis Reports|May 24, 2023
In-Hospital Use of PCSK9 Inhibitors in the Post ACS Patient: What Does the Evidence Show?Mario Enrico Canonico, Connie N Hess, Christopher P CannonPageof 193